LEHVOSS Nutrition and MSP bring upcycled prebiotic resistant potato starch to Europe

Nutraceutical and supplement ingredient provider LEHVOSS Nutrition is partnering with Canadian prebiotic ingredient maker MSP Starch Products to bring its prebiotic resistant potato starch (RS2), Solnul, to European formulators. The companies say the agreement marks a significant step in the innovative ingredient’s global commercial expansion.

The move brings the science-backed, upcycled solution to one of the world’s most active gut health markets at a time when demand for natural digestive health solutions is accelerating across the continent. 

Innova Market Insights’ data suggests that half of global consumers select food and beverages (F&B) for gut health, spurring category innovation. At the same time, prebiotic supplement launches grew 10% annually from 2020–2024, with digestive, immune, and energy claims leading the category. 

“Our gut health portfolio is intentionally selective and built around credible, science-backed ingredients,” says Paul Montgomery, head of product management at LEHVOSS Nutrition. “Solnul strengthens our fiber and whole food ingredients offering.” 

Europe’s growing appetite

Solnul is a patented and upcycled RS2 ingredient. It is positioned for use in dietary supplements and functional F&B applications. It is derived from ingredients that would otherwise go to waste and is supported by a body of clinical and scientific research that demonstrates its efficacy at low doses. It also has a strong tolerability profile. 

According to MSP, the ingredient is associated with improved regularity, gut barrier function, nutrient absorption, and metabolic health. 

For formulators, it offers label-friendly positioning and a suite of verified certifications, including Upcycled Certified, FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) Friendly, gluten-free, glyphosate residue-free, and Non-GMO Project Verified. 

“As demand for fiber continues to grow across Europe, this expansion advances our mission to reunite the microbiome with its favorite food, Solnul, and to bring the benefits of resistant starch to a broader audience,” says Jason Leibert, the chief growth officer at Solnul. 

“Today, the average European consumes only around 4 g of the recommended 20 g of resistant starch per day — highlighting how far modern diets have moved away from this foundational fiber.” 

Industry visibility

The European launch will be formally showcased at Vitafoods Europe 2026, in Barcelona, Spain (May 5–6). The ingredient will be presented at LEHVOSS’ stand #3C72, and MSP has secured a speaking slot at the Vitafoods Insights Theatre (6H2) on May 6. A panel discussion will focus on upcycling and circular ingredient sourcing. 

Furthermore, LEHVOSS emphasizes that the partnership provides ingredient buyers and product developers with a structured sourcing pathway for Solnul, backed by local technical support. The company says it will help customers translate the ingredient’s clinical research into practical formulation guidance to facilitate broader adoption of resistant starch. 

“We are confident that our LEHVOSS Nutrition Health Platform, combined with the recent integration of our AI product assistant, will empower and educate our customers to seamlessly and efficiently incorporate this outstanding and on-trend ingredient into their products,” explains Teresita Rudà, the head of marketing and brand positioning at LEHVOSS Nutrition. 

Timing the market

LEHVOSS Nutrition reveals that the timing of the partnership reflects broader market dynamics. Interest in resistant starch — and the distinct type of fermentable fiber it provides — is rising across Europe as both brands and consumers prioritize gut health. 

Additionally, the company points out that prebiotics, probiotics, and digestive enzymes are among the fastest-growing categories in the region’s health supplement and functional food sectors. Meanwhile, clean label and naturally sourced ingredient demand continue to shape markets. 

MSP says the partnership represents a long-awaited entry point for European manufacturers seeking a well-tolerated, scientifically validated microbiome ingredient with an established regional distribution network.